The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
They do seem to be involved in proteomics
What I liked about avacta was their veterinary side life sciences dealing with infectious diseases
Some links
https://avacta.com/2014-11-13/
https://avacta.com/2014-08-19/
Really ? How do I have that inkling ? I’m in Avacta too but not been following the recent rise . Proteome seems to be involved with supplying many well known diagnostic companies for their diagnostics and spectrometry .. let’s hope this is true and we get some publicity .. tell us more and welcome to proteome sciences .. it’s been well below the radar 4 months.. communication is not their strong area. However things seem to be slightly improving so chin up and let’s hope my gut instinct in this company proves correct .
Yes, Considering the float is so small
Thermofisher , AstraZeneca , all the big players, all biotechs need and will be having proteomics at the centre for sustained growth & develoment
https://www.pharmaceuticalcommerce.com/view/thermo-fisher-scientific-receives-substantial-bioprocessing-investments
Have u seen this .. if ur interested in webinars and to get the latest on PROTEOME SCIENCES. Well done!
https://twitter.com/investormeetco/status/1371376822764634113?s=21
And this is a very nice start for the week
https://www.news-medical.net/news/20210304/The-Role-of-D-Amino-Acids-in-Humans.aspx
Happy weekend :)
No movement due to no news .. wonder what they have planned ? What is is going to be tied in with ? Hopefully once we know the target this can gain momentum at much higher levels ..
Bit dismal .. time for lex to bring out some PR communication dont ya think ?
Manchester also is a place that is giving grants to help businesses , biotech and start ups , to make it a centre of excellence ..
this is interesting how scientists are building up a
Proteome database using mass spectrometry
https://www.manchester.ac.uk/coronavirus-response/science-engineering-coronavirus-projects/mass-spectrometry-coalition/
I heard it also on radio 4 the uni of Manchester is doing something like a test in the skins sebum oil layer to diagnose it
The article says
The research team moved on to using a mass-spectrometry machine to detect the compounds.
So u think they are working with proteome sciences?
Where is is it mentioning proteome sciences ?
I know they are into this area of Neuro degenerative disease of Alzheimer’s / Parkinson’s .
Hmm a lull before the storm ? No market reaction but v quiet today all round .. very happy and liking the regular communication PC
Yes I noticed that the spread has normalised . Hopefully interest in proteomics is increasing.
Very nice analogy saint tropez
Lol .. the more liquid the less the spread .. more investors and buying please and let’s get proteomics talked about .. increase awareness in precision medicine and A I health data collaboration
We are the bedrock small investors building the base -and good to know larger institutional investors are also seeing potential .. who would have thought eua go up so much .. I came in on that one at 2.6p .. if we come in now we can be well ahead of the curve .. I think we are set for some good surprises shortly .
A few big investors and some decent communication , PR & knowledge would propel this past the 5p ..
Mariola has connections with Chinese companies trying to enter the western biotech markets .. if proteome sciences is a world leader in this field they need to grow and hire people rather than aiming to stay small /insignificant .. or be bought out for considerable upside to their shareholders.. do lack of news may be in their interest to keep prices suppressed. AstraZeneca & novacyt springs to my mind .. another good fit would be deepmatter and digital data health companies or bigger cancer & immunotherapy biotechs . I am still betting on proteome sciences .. I just hope my faith in them ultimately rewards..
“Scandinavia already has a strong position internationally in proteomics, and in the future we expect that this will result in more start-up companies that could generate interesting, innovative technologies in proteomics, including improvements in bioinformatics, protein arrays, and nanotechnology solutions for protein analysis,” said Bob Galvin, European business development manager at Applied Biosystems.